Thursday, October 15, 2026
ExploreSearch
Via News
Via News Knowledge File

New York Stock Exchange

organization80% conf.·synced Oct 15, 2026

Stock exchange where The Hartford is listed

5
sourced metrics
1515
relationships
11
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Trading Days
5days_per_week
source
Trading Hours
6.5hours_per_day
source
Closing Auction Notional Value
230.5USD
Mar 27, 2026source
Closing Auction Shares Traded
3.57billion_shares
Mar 27, 2026source
Average Holding Period
5.5months
Jan 1, 2020⚠ sources conflictsource

Stated objectives

Enable 24/7 trading through stock tokenization

source
stated

Launch blockchain-powered platform enabling 24/7 trading of tokenized stocks and ETFs

source
target: 24/7 trading availability by 2025-01-01 00:00:00stated

Develop digital transfer agent program to support on-chain settlement of tokenized security transactions

source
stated

Collaborate on development of standards for digital transfer agents and tokenization agents participating in the digital ecosystem, focusing on regulatory, operational, and technology requirements for institutional-grade tokenized securities infrastructure

source
stated

Develop digital transfer agent program to support on-chain settlement of tokenized security transactions

source
stated

Develop standards for digital transfer agents and tokenization agents participating in the digital ecosystem, focusing on regulatory, operational, and technology requirements for institutional-grade tokenized securities infrastructure

source
stated

Develop digital transfer agent program to support on-chain settlement of tokenized security transactions

source
stated

Collaborate on development of standards for digital transfer agents and tokenization agents, establishing regulatory, operational, and technology requirements for institutional-grade tokenized securities infrastructure

source
stated

Supporting tokenized stocks and ETFs within existing market infrastructure

source
stated

Build a blockchain venue allowing trading of tokenized stocks and ETFs around the clock

source
stated

Relationship graph · 1515 connections

listed on
1049
located in
309
trades on
40
regulates
23
Employs
12
subsidiary of
8
Owns
8
Covered by
7
Built on
Blockchain
Customer of
AEVEX Corp.

Via News coverage

NVIDIA Lands Nine Global Enterprise Partners in 48 Hours at GTC Taipei, Spanning Five Industries
June 8, 2026
Copa Airlines and the Single-Hub Trap: A Global Lesson in Aviation Concentration Risk
February 18, 2026
Copa Holdings and the Single-Hub Trap: A Global Warning for Concentrated Aviation Networks
February 18, 2026
Takeda Phases Out Legacy IVIG Product as Global Immunoglobulin Market Shifts Toward Next-Generation Therapies
February 18, 2026
Aegon's US Pivot: What the Transamerica Rebrand Means for Global Insurance Markets
February 18, 2026
Argan And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity
September 16, 2024
Sprott Focus Trust, ARC Document Solutions, Another 6 Companies Have A High Estimated Dividend Yield
September 16, 2024
CrowdStrike Holdings And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity
September 13, 2024
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com